_id
691b17e73c536f8df2318bea
Ticker
NANO.PA
Name
Nanobiotix S.A
Exchange
PA
Address
60 rue de Wattignies, Paris, France, 75012
Country
France
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://www.nanobiotix.com
Description
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Last Close
19
Volume
53955
Current Price
17.6
Change
0.16
Last Updated
2025-12-31T16:00:31.660Z
Image
https://logo.clearbit.com/www.nanobiotix.com
Ipo Date
-
Market Cap
935649856
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.2
Strong Buy
1
Buy
4
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
26638000
Cost Of Revenue
-
Gross Profit
26638000
Operating Expenses
25830000
Operating Income
808000
Interest Expense
3645000
Pretax Income
-5377000
Net Income
-5383000
Eps
-0.11352192003252763
Dividends Per Share
-
Shares Outstanding
48379000
Income Tax Expense
6000
EBITDA
1091000
Operating Margin
3.0332607553119604
Total Other Income Expense Net
-6185000
Cash
28818000
Short Term Investments
-
Receivables
1837000
Inventories
-
Total Current Assets
39889000
Property Plant Equipment
4613000
Total Assets
45174000
Payables
4226000
Short Term Debt
4735000
Long Term Debt
44120000
Total Liabilities
114126000
Equity
-68952000
Bs_currency_symbol
EUR
Depreciation
800000
Change In Working Capital
383000
Cash From Operations
-17411000
Capital Expenditures
150000
Cash From Investing
-162000
Cash From Financing
-2830000
Net Change In Cash
28818000
Cf_currency_symbol
-
PE
-
PB
-12.103485439146073
ROE
7.806880148509107
ROA
-11.916146455925974
FCF
-17561000
Fcf Percent
-0.6592461896538779
Piotroski FScore
0
Health Score
20
Deep Value Investing Score
0.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
4
Net Net Investing Score
0.5
Quality Investing Score
0.5
Value Investing Score
1
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
26638000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
26638000
Quarters > 0 > income Statement > operating Expenses
25830000
Quarters > 0 > income Statement > operating Income
808000
Quarters > 0 > income Statement > interest Expense
3645000
Quarters > 0 > income Statement > pretax Income
-5377000
Quarters > 0 > income Statement > net Income
-5383000
Quarters > 0 > income Statement > eps
-0.11352192003252763
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
47418155
Quarters > 0 > income Statement > income Tax Expense
6000
Quarters > 0 > income Statement > EBITDA
1091000
Quarters > 0 > income Statement > operating Margin
3.0332607553119604
Quarters > 0 > income Statement > total Other Income Expense Net
-6185000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
28818000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1837000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
39889000
Quarters > 0 > balance Sheet > property Plant Equipment
4613000
Quarters > 0 > balance Sheet > total Assets
45174000
Quarters > 0 > balance Sheet > payables
4226000
Quarters > 0 > balance Sheet > short Term Debt
4735000
Quarters > 0 > balance Sheet > long Term Debt
44120000
Quarters > 0 > balance Sheet > total Liabilities
114126000
Quarters > 0 > balance Sheet > equity
-68952000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-5383000
Quarters > 0 > cash Flow > depreciation
800000
Quarters > 0 > cash Flow > change In Working Capital
383000
Quarters > 0 > cash Flow > cash From Operations
-17411000
Quarters > 0 > cash Flow > capital Expenditures
150000
Quarters > 0 > cash Flow > cash From Investing
-162000
Quarters > 0 > cash Flow > cash From Financing
-2830000
Quarters > 0 > cash Flow > net Change In Cash
28818000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.11352192003252763
Quarters > 0 > ratios > PB
-12.103485439146073
Quarters > 0 > ratios > ROE
7.806880148509107
Quarters > 0 > ratios > ROA
-11.916146455925974
Quarters > 0 > ratios > FCF
-17561000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-0.6592461896538779
Quarters > 0 > health Score
20
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
-20898000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-20898000
Quarters > 1 > income Statement > operating Expenses
23842000
Quarters > 1 > income Statement > operating Income
-44740000
Quarters > 1 > income Statement > interest Expense
8086000
Quarters > 1 > income Statement > pretax Income
-46303000
Quarters > 1 > income Statement > net Income
-46260000
Quarters > 1 > income Statement > eps
-0.9787329952282641
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
47265189
Quarters > 1 > income Statement > income Tax Expense
-43000
Quarters > 1 > income Statement > EBITDA
-44422000
Quarters > 1 > income Statement > operating Margin
214.0874724854053
Quarters > 1 > income Statement > total Other Income Expense Net
-1563000
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
49737000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
8535000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
61466000
Quarters > 1 > balance Sheet > property Plant Equipment
5538000
Quarters > 1 > balance Sheet > total Assets
67418000
Quarters > 1 > balance Sheet > payables
4484000
Quarters > 1 > balance Sheet > short Term Debt
4924000
Quarters > 1 > balance Sheet > long Term Debt
43009000
Quarters > 1 > balance Sheet > total Liabilities
133121000
Quarters > 1 > balance Sheet > equity
-65703000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-46260000
Quarters > 1 > cash Flow > depreciation
835000
Quarters > 1 > cash Flow > change In Working Capital
16776000
Quarters > 1 > cash Flow > cash From Operations
-13715000
Quarters > 1 > cash Flow > capital Expenditures
357000
Quarters > 1 > cash Flow > cash From Investing
-455000
Quarters > 1 > cash Flow > cash From Financing
-2480000
Quarters > 1 > cash Flow > net Change In Cash
-16598000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-0.9787329952282641
Quarters > 1 > ratios > PB
-12.661025012556506
Quarters > 1 > ratios > ROE
70.40774393863293
Quarters > 1 > ratios > ROA
-68.61668990477321
Quarters > 1 > ratios > FCF
-14072000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
0.6733658723322806
Quarters > 1 > health Score
49
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
9289000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
9289000
Quarters > 2 > income Statement > operating Expenses
32941000
Quarters > 2 > income Statement > operating Income
-23652000
Quarters > 2 > income Statement > interest Expense
3861000
Quarters > 2 > income Statement > pretax Income
-21728000
Quarters > 2 > income Statement > net Income
-21872000
Quarters > 2 > income Statement > eps
-0.4641360669034994
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
47124112
Quarters > 2 > income Statement > income Tax Expense
144000
Quarters > 2 > income Statement > EBITDA
-23244000
Quarters > 2 > income Statement > operating Margin
-254.62374851975454
Quarters > 2 > income Statement > total Other Income Expense Net
1924000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
66335000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
3121000
Quarters > 2 > balance Sheet > inventories
2269000
Quarters > 2 > balance Sheet > total Current Assets
80456000
Quarters > 2 > balance Sheet > property Plant Equipment
5907000
Quarters > 2 > balance Sheet > total Assets
86680000
Quarters > 2 > balance Sheet > payables
4766000
Quarters > 2 > balance Sheet > short Term Debt
5000000
Quarters > 2 > balance Sheet > long Term Debt
40726000
Quarters > 2 > balance Sheet > total Liabilities
108457000
Quarters > 2 > balance Sheet > equity
-21777000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-21872000
Quarters > 2 > cash Flow > depreciation
786000
Quarters > 2 > cash Flow > change In Working Capital
-2493000
Quarters > 2 > cash Flow > cash From Operations
-6356000
Quarters > 2 > cash Flow > capital Expenditures
489000
Quarters > 2 > cash Flow > cash From Investing
-500000
Quarters > 2 > cash Flow > cash From Financing
-2135000
Quarters > 2 > cash Flow > net Change In Cash
-8948000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-0.4641360669034994
Quarters > 2 > ratios > PB
-38.085336419157834
Quarters > 2 > ratios > ROE
100.43624006979842
Quarters > 2 > ratios > ROA
-25.23304107060452
Quarters > 2 > ratios > FCF
-6845000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.7368930993648402
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
32915000
Quarters > 3 > income Statement > cost Of Revenue
-2857000
Quarters > 3 > income Statement > gross Profit
32915000
Quarters > 3 > income Statement > operating Expenses
34324000
Quarters > 3 > income Statement > operating Income
-1409000
Quarters > 3 > income Statement > interest Expense
4165000
Quarters > 3 > income Statement > pretax Income
-11484000
Quarters > 3 > income Statement > net Income
-11601000
Quarters > 3 > income Statement > eps
-0.29884642343866846
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
38819270
Quarters > 3 > income Statement > income Tax Expense
117000
Quarters > 3 > income Statement > EBITDA
-4942000
Quarters > 3 > income Statement > operating Margin
-4.280723074586055
Quarters > 3 > income Statement > total Other Income Expense Net
-10075000
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
75283000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
9495000
Quarters > 3 > balance Sheet > inventories
200000
Quarters > 3 > balance Sheet > total Current Assets
87339000
Quarters > 3 > balance Sheet > property Plant Equipment
6251000
Quarters > 3 > balance Sheet > total Assets
93897000
Quarters > 3 > balance Sheet > payables
6695000
Quarters > 3 > balance Sheet > short Term Debt
5022000
Quarters > 3 > balance Sheet > long Term Debt
41660000
Quarters > 3 > balance Sheet > total Liabilities
95740000
Quarters > 3 > balance Sheet > equity
-1843000
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-11601000
Quarters > 3 > cash Flow > depreciation
772000
Quarters > 3 > cash Flow > change In Working Capital
4241000
Quarters > 3 > cash Flow > cash From Operations
4799000
Quarters > 3 > cash Flow > capital Expenditures
5000
Quarters > 3 > cash Flow > cash From Investing
-22000
Quarters > 3 > cash Flow > cash From Financing
48909000
Quarters > 3 > cash Flow > net Change In Cash
53654000
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-0.29884642343866846
Quarters > 3 > ratios > PB
-370.7103374932176
Quarters > 3 > ratios > ROE
629.4628323385784
Quarters > 3 > ratios > ROA
-12.355027317166682
Quarters > 3 > ratios > FCF
4794000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.1456478809053623
Quarters > 3 > health Score
44
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
-11609000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-11609000
Annuals > 0 > income Statement > operating Expenses
56783000
Annuals > 0 > income Statement > operating Income
-68392000
Annuals > 0 > income Statement > interest Expense
8085000
Annuals > 0 > income Statement > pretax Income
-68031000
Annuals > 0 > income Statement > net Income
-68132000
Annuals > 0 > income Statement > eps
-1.4414837101360158
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
47265189
Annuals > 0 > income Statement > income Tax Expense
101000
Annuals > 0 > income Statement > EBITDA
-61624000
Annuals > 0 > income Statement > operating Margin
589.1291239555518
Annuals > 0 > income Statement > total Other Income Expense Net
361000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
49737000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
8535000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
61466000
Annuals > 0 > balance Sheet > property Plant Equipment
5538000
Annuals > 0 > balance Sheet > total Assets
67418000
Annuals > 0 > balance Sheet > payables
4484000
Annuals > 0 > balance Sheet > short Term Debt
4924000
Annuals > 0 > balance Sheet > long Term Debt
43009000
Annuals > 0 > balance Sheet > total Liabilities
133121000
Annuals > 0 > balance Sheet > equity
-65703000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-68132000
Annuals > 0 > cash Flow > depreciation
1621000
Annuals > 0 > cash Flow > change In Working Capital
14283000
Annuals > 0 > cash Flow > cash From Operations
-19551000
Annuals > 0 > cash Flow > capital Expenditures
846000
Annuals > 0 > cash Flow > cash From Investing
-955000
Annuals > 0 > cash Flow > cash From Financing
-5135000
Annuals > 0 > cash Flow > net Change In Cash
-25546000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-1.4414837101360158
Annuals > 0 > ratios > PB
-14.027840212775672
Annuals > 0 > ratios > ROE
103.69693925695935
Annuals > 0 > ratios > ROA
-101.05906434483371
Annuals > 0 > ratios > FCF
-20397000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
1.7569988801791714
Annuals > 0 > health Score
48
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
30058000
Annuals > 1 > income Statement > cost Of Revenue
-6150000
Annuals > 1 > income Statement > gross Profit
30058000
Annuals > 1 > income Statement > operating Expenses
56837000
Annuals > 1 > income Statement > operating Income
-26779000
Annuals > 1 > income Statement > interest Expense
7982000
Annuals > 1 > income Statement > pretax Income
-39580000
Annuals > 1 > income Statement > net Income
-39700000
Annuals > 1 > income Statement > eps
-1.0750603042485651
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
36928161
Annuals > 1 > income Statement > income Tax Expense
120000
Annuals > 1 > income Statement > EBITDA
-30085000
Annuals > 1 > income Statement > operating Margin
-89.09109055825404
Annuals > 1 > income Statement > total Other Income Expense Net
-12801000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
75283000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
9495000
Annuals > 1 > balance Sheet > inventories
200000
Annuals > 1 > balance Sheet > total Current Assets
87339000
Annuals > 1 > balance Sheet > property Plant Equipment
6251000
Annuals > 1 > balance Sheet > total Assets
93897000
Annuals > 1 > balance Sheet > payables
6695000
Annuals > 1 > balance Sheet > short Term Debt
5022000
Annuals > 1 > balance Sheet > long Term Debt
41660000
Annuals > 1 > balance Sheet > total Liabilities
95740000
Annuals > 1 > balance Sheet > equity
-1843000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-39700000
Annuals > 1 > cash Flow > depreciation
1513000
Annuals > 1 > cash Flow > change In Working Capital
9920000
Annuals > 1 > cash Flow > cash From Operations
-12476000
Annuals > 1 > cash Flow > capital Expenditures
328000
Annuals > 1 > cash Flow > cash From Investing
-349000
Annuals > 1 > cash Flow > cash From Financing
46771000
Annuals > 1 > cash Flow > net Change In Cash
33895000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-1.0750603042485651
Annuals > 1 > ratios > PB
-390.7211825827455
Annuals > 1 > ratios > ROE
2154.0965816603366
Annuals > 1 > ratios > ROA
-42.28037104486832
Annuals > 1 > ratios > FCF
-12804000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.42597644553862535
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
4776000
Annuals > 2 > income Statement > cost Of Revenue
1500000
Annuals > 2 > income Statement > gross Profit
3276000
Annuals > 2 > income Statement > operating Expenses
48993000
Annuals > 2 > income Statement > operating Income
-50493000
Annuals > 2 > income Statement > interest Expense
5837000
Annuals > 2 > income Statement > pretax Income
-61122000
Annuals > 2 > income Statement > net Income
-57041000
Annuals > 2 > income Statement > eps
-1.636669804901132
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
34851868
Annuals > 2 > income Statement > income Tax Expense
-4081000
Annuals > 2 > income Statement > EBITDA
-53785000
Annuals > 2 > income Statement > operating Margin
-1057.2236180904522
Annuals > 2 > income Statement > total Other Income Expense Net
-10629000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
38576000
Annuals > 2 > balance Sheet > short Term Investments
2813000
Annuals > 2 > balance Sheet > receivables
2842000
Annuals > 2 > balance Sheet > inventories
100000
Annuals > 2 > balance Sheet > total Current Assets
52358000
Annuals > 2 > balance Sheet > property Plant Equipment
7120000
Annuals > 2 > balance Sheet > total Assets
59769000
Annuals > 2 > balance Sheet > payables
3999000
Annuals > 2 > balance Sheet > short Term Debt
4560000
Annuals > 2 > balance Sheet > long Term Debt
44040000
Annuals > 2 > balance Sheet > total Liabilities
86814000
Annuals > 2 > balance Sheet > equity
-27045000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-57041000
Annuals > 2 > cash Flow > depreciation
1500000
Annuals > 2 > cash Flow > change In Working Capital
2300000
Annuals > 2 > cash Flow > cash From Operations
-37103000
Annuals > 2 > cash Flow > capital Expenditures
93000
Annuals > 2 > cash Flow > cash From Investing
138000
Annuals > 2 > cash Flow > cash From Financing
-5651000
Annuals > 2 > cash Flow > net Change In Cash
-42533000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-1.636669804901132
Annuals > 2 > ratios > PB
-25.128912035496395
Annuals > 2 > ratios > ROE
210.91144388981328
Annuals > 2 > ratios > ROA
-95.43576101323428
Annuals > 2 > ratios > FCF
-37196000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-7.788107202680067
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
10000
Annuals > 3 > income Statement > cost Of Revenue
-2637000
Annuals > 3 > income Statement > gross Profit
2647000
Annuals > 3 > income Statement > operating Expenses
55226000
Annuals > 3 > income Statement > operating Income
-52579000
Annuals > 3 > income Statement > interest Expense
671000
Annuals > 3 > income Statement > pretax Income
-49489000
Annuals > 3 > income Statement > net Income
-47003000
Annuals > 3 > income Statement > eps
-1.3532500602157842
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
34733418
Annuals > 3 > income Statement > income Tax Expense
-2486000
Annuals > 3 > income Statement > EBITDA
-45605000
Annuals > 3 > income Statement > operating Margin
-525790
Annuals > 3 > income Statement > total Other Income Expense Net
5581000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
83921000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
3883000
Annuals > 3 > balance Sheet > inventories
-3043000
Annuals > 3 > balance Sheet > total Current Assets
93060000
Annuals > 3 > balance Sheet > property Plant Equipment
8186000
Annuals > 3 > balance Sheet > total Assets
101671000
Annuals > 3 > balance Sheet > payables
4996000
Annuals > 3 > balance Sheet > short Term Debt
8204000
Annuals > 3 > balance Sheet > long Term Debt
32423000
Annuals > 3 > balance Sheet > total Liabilities
74979000
Annuals > 3 > balance Sheet > equity
26692000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-47003000
Annuals > 3 > cash Flow > depreciation
1560000
Annuals > 3 > cash Flow > change In Working Capital
11540000
Annuals > 3 > cash Flow > cash From Operations
-31004000
Annuals > 3 > cash Flow > capital Expenditures
233000
Annuals > 3 > cash Flow > cash From Investing
-242000
Annuals > 3 > cash Flow > cash From Financing
-4048000
Annuals > 3 > cash Flow > net Change In Cash
-35230000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-1.3532500602157842
Annuals > 3 > ratios > PB
25.374705941855236
Annuals > 3 > ratios > ROE
-176.09396073729957
Annuals > 3 > ratios > ROA
-46.230488536554184
Annuals > 3 > ratios > FCF
-31237000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-3123.7
Annuals > 3 > health Score
12
Valuation > metrics > PE
-0.11352192003252763
Valuation > metrics > PB
-12.103485439146073
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
7.806880148509107
Profitability > metrics > ROA
-13.494948482037655
Profitability > metrics > Net Margin
-0.20207973571589458
Profitability > final Score
16
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
0.2216735253772291
Risk > final Score
31
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.451400513335566
Liquidity > metrics > Quick Ratio
4.451400513335566
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
70
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
8
Prev Risks > 1
5
Prev Risks > 2
29
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:10:16.060Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-19
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-03-31
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Stock Price
€0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ANuScale Power vs. Nano Nuclear Energy: Which Stock Will Make You Richer? Nasdaq
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
1
Buy
4
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Nanobiotix S.A
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.